Semler Scientific Stock Today
| SMLR Stock | USD 40.04 4.55 12.82% |
PerformanceVery Weak
| Odds Of DistressVery Low
|
Semler Scientific is selling at 40.04 as of the 20th of March 2025; that is 12.82 percent increase since the beginning of the trading day. The stock's lowest day price was 36.32. Semler Scientific has under 5 % chance of experiencing financial distress over the next 2 years, but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 20th of December 2024 and ending today, the 20th of March 2025. Click here to learn more.
Business Domain Health Care Equipment & Services | IPO Date 21st of February 2014 | Category Healthcare | Classification Health Care |
Semler Scientific, Inc. provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers in the United States. Semler Scientific, Inc. was incorporated in 2007 and is headquartered in Santa Clara, California. Semler Scientific operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. The company has 9.6 M outstanding shares of which 1.74 M shares are at this time shorted by private and institutional investors with about 4.71 trading days to cover. More on Semler Scientific
Moving against Semler Stock
Semler Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| President CEO | Douglas MD | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, NASDAQ Composite, NASDAQ Health Care, NASDAQ Composite Total, Health Care, Health Care Equipment & Supplies, Medical Devices, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsSemler Scientific can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Semler Scientific's financial leverage. It provides some insight into what part of Semler Scientific's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Semler Scientific (SMLR) is traded on NASDAQ Exchange in USA. It is located in 2340-2348 Walsh Avenue, Santa Clara, CA, United States, 95051 and employs 79 people. Semler Scientific is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 345.76 M. Semler Scientific conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 9.6 M outstanding shares of which 1.74 M shares are at this time shorted by private and institutional investors with about 4.71 trading days to cover.
Semler Scientific currently holds about 40.03 M in cash with 24.41 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.89.
Check Semler Scientific Probability Of Bankruptcy
Ownership AllocationThe market capitalization of Semler Scientific is $345.76 Million. Over half of Semler Scientific's outstanding shares are owned by institutional holders. These institutional holders are typically referred to as corporate investors that take positions in a given instrument to benefit from reduced trade commissions. Please take into account that even companies with profitable outlook can generate negative future returns on their equity. If the true value of the company is less than the current market value, you may not be able generate positive returns on investment in the long run.
Check Semler Ownership Details
Semler Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Goldman Sachs Group Inc | 2024-12-31 | 113 K | |
| Principal Financial Group Inc | 2024-12-31 | 112.5 K | |
| Lpl Financial Corp | 2024-12-31 | 110.6 K | |
| Amvescap Plc. | 2024-12-31 | 110.4 K | |
| Wells Fargo & Co | 2024-12-31 | 103.5 K | |
| State Street Corp | 2024-12-31 | 100.5 K | |
| Exchange Traded Concepts, Llc | 2024-12-31 | 61.4 K | |
| Macquarie Group Ltd | 2024-12-31 | 60.7 K | |
| Northern Trust Corp | 2024-12-31 | 52.4 K | |
| Morgan Stanley - Brokerage Accounts | 2024-12-31 | 626.4 K | |
| Capital Research & Mgmt Co - Division 3 | 2024-12-31 | 570.6 K |
Semler Scientific Historical Income Statement
Semler Stock Against Markets
Semler Scientific Corporate Management
| Jennifer Herrington | Chief Officer | Profile | |
| Dennis Rosenberg | Chief Officer | Profile | |
| Shane Reid | Chief Officer | Profile | |
| Cindy Guinasso | Senior Development | Profile |
Additional Tools for Semler Stock Analysis
When running Semler Scientific's price analysis, check to measure Semler Scientific's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Semler Scientific is operating at the current time. Most of Semler Scientific's value examination focuses on studying past and present price action to predict the probability of Semler Scientific's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Semler Scientific's price. Additionally, you may evaluate how the addition of Semler Scientific to your portfolios can decrease your overall portfolio volatility.